Skip to content
Spectrum Pharmaceuticals logo — Innovative solutions driving advancements in cancer treatmen...

Spectrum Pharmaceuticals

Innovative solutions driving advancements in cancer treatment through strategic development and commercialization of unique therapeutic products.

Founded 1987 51-200 employees Post-IPO Debt Total: $235.98M Biopharma, Biotechnology +1

General Information

Company Name Spectrum Pharmaceuticals
Founded Year 1987
Employees 51-200
Industries Biopharma, Biotechnology, Health Care
Funding Stage Post-IPO Debt
Social

BounceWatch is an independent company data service, not affiliated with Spectrum Pharmaceuticals. To contact Spectrum Pharmaceuticals, visit sppirx.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Spectrum Pharmaceuticals compare?

A PDF of Spectrum Pharmaceuticals and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Spectrum Pharmaceuticals soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Spectrum Pharmaceuticals

Spectrum Pharmaceuticals is a biopharmaceutical company founded in 1987, with a focus on acquiring, developing, and commercializing innovative and targeted drug products within the field of oncology. The company's slogan emphasizes its commitment to driving advancements in cancer treatment through strategic development and commercialization of unique therapeutic products. Spectrum Pharmaceuticals has established an impressive track record in in-licensing and acquiring unique drugs, as well as in clinical development. Its last investment of $30.00M, a Post-IPO Debt investment, was made on 23 September 2022 and was led by SLR Capital Partners. The company operates within the industries of Biopharma, Biotechnology, and Health Care.

Business keywords: biopharmaceutical company, oncology, therapeutic products, drug development, clinical development, commercialization, targeted drug products, innovation, acquisition, licensing, cancer treatment, strategic development

Funding Rounds & Investors (9)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Debt $30.00M 1
SLR Capital Partners
23 Sep 2022
Post IPO Equity $20.00M 1
Hanmi Pharmaceutical
04 Jan 2022
Post IPO Equity $65.00M -
29 Jul 2020
Post IPO Equity $3.00M -
29 Apr 2016
Grant $977.90K -
03 Nov 2010
Post IPO Equity $20.00M 1
Par Pharmaceuticals
07 May 2008
Post IPO Equity $30.00M 3
Perceptive Advisors, SDS Capital Group +1
11 May 2007
Post IPO Equity $42.00M -
15 Sep 2005
Post IPO Equity $25.00M -
21 Apr 2004

Spectrum Pharmaceuticals Alternatives & Competitors

View All Alternatives
Spectrum Pharmaceuticals vs

Empowering cancer care in China through a robust network of global partnerships, innovative drug dev...

Series C
Biopharma, Biotechnology
Spectrum Pharmaceuticals vs

developing innovative drugs and drug delivery systems that improve the quality of life of oncology p...

Series A
7 employees
Biopharma, Biotechnology
Spectrum Pharmaceuticals vs
Apollomics
Apollomics United States

We are a biopharmaceutical company committed to the discovery and development of mono- and combinati...

Post-IPO Equity
26 employees
Biotechnology, Health Care

FAQ About Spectrum Pharmaceuticals

Innovative solutions driving advancements in cancer treatment through strategic development and commercialization of unique therapeutic products.
Spectrum Pharmaceuticals was founded in 1987.
Spectrum Pharmaceuticals operates in Biopharma, Biotechnology and Health Care. Its work centres on biopharmaceutical company, oncology, therapeutic products and drug development.
Spectrum Pharmaceuticals has approximately 51-200 employees.
Spectrum Pharmaceuticals has completed 9 funding rounds, raising a total of $235.98M. The latest funding stage is Post-IPO Debt.
Top alternatives and competitors to Spectrum Pharmaceuticals include EOC Pharma Group, OnQuality Pharmaceuticals Ltd., Apollomics, Xynomic Pharma, Adlai Nortye. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Spectrum Pharmaceuticals and EOC Pharma Group are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Spectrum Pharmaceuticals, https://bouncewatch.com/company/spectrum-pharmaceuticals, updated 20 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout